Halozyme Therapeutics, Inc. (HALO): Price and Financial Metrics
HALO Price/Volume Stats
| Current price | $46.96 | 52-week high | $65.53 |
| Prev. close | $47.32 | 52-week low | $33.15 |
| Day low | $46.88 | Volume | 4,794,800 |
| Day high | $48.21 | Avg. volume | 1,379,155 |
| 50-day MA | $51.00 | Dividend yield | N/A |
| 200-day MA | $50.19 | Market Cap | 5.97B |
HALO Stock Price Chart Interactive Chart >
Halozyme Therapeutics, Inc. (HALO) Company Bio
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company was founded in 1998 and is based in San Diego, California.
HALO Price Returns
| 1-mo | 2.76% |
| 3-mo | -20.73% |
| 6-mo | -9.80% |
| 1-year | 26.41% |
| 3-year | 18.80% |
| 5-year | 154.11% |
| YTD | 27.06% |
| 2023 | -35.04% |
| 2022 | 41.51% |
| 2021 | -5.85% |
| 2020 | 140.89% |
| 2019 | 21.19% |
Continue Researching HALO
Want to see what other sources are saying about Halozyme Therapeutics Inc's financials and stock price? Try the links below:Halozyme Therapeutics Inc (HALO) Stock Price | Nasdaq
Halozyme Therapeutics Inc (HALO) Stock Quote, History and News - Yahoo Finance
Halozyme Therapeutics Inc (HALO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...